DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Small EJ, Lee JY, Lopez-Gitlitz A. et al.
PD10-11 PROSTATE-SPECIFIC ANTIGEN (PSA) OUTCOMES IN PATIENTS (PTS) WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) TREATED WITH APALUTAMIDE (APA): RESULTS FROM PHASE 3 SPARTAN STUDY.
J Urol 2018;
199: e232-e232
DOI: 10.1016/j.juro.2018.02.621.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.